Predicting Circulating CA125 Levels among Healthy Premenopausal Women.
Naoko SasamotoAna BabicBernard A RosnerRenée Turzanski FortnerAllison F VitonisHidemi YamamotoRaina N FichorovaAnne TjønnelandLouise HansenKim OvervadMarina KvaskoffAgnès FournierFrancesca Romana ManciniHeiner BoeingAntonia TrichopoulouEleni PeppaAnna KarakatsaniDomenico PalliValeria PalaAmalia MattielloRosario TuminoChiara C GrassoN Charlotte Onland-MoretElisabete WeiderpassJ Ramón QuirósLeila Lujan-BarrosoMiguel Rodríguez BarrancoSandra Colorado-YoharAurelio Barricarte-GurreaMiren DorronsoroAnnika IdahlEva LundinHanna SartorKay-Tee KhawTimothy J KeyDavid MullerElio RiboliMarc J GunterLaure DossusRudolf KaaksDaniel W CramerShelley T TworogerKathryn L TerryPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)
Our model could be valuable in identifying healthy women likely to have elevated CA125 and consequently improve its specificity for ovarian cancer screening.